Ruth Webster from the George Institute in Sydney, Australia, discusses the potential of polypills to prevent atherosclerosis as part of a wider plan to meet non-communicable disease targets by 2025.

Emily Mendenhall discusses a new Lancet Series, explaining the new health concept of syndemics and how it can be used to tackle health inequities.

Subra Kugathasan discusses his Article which creates a risk-stratification model to predict the risk of developing complications in paediatric patients with newly diagnosed Crohn’s disease.

Majid Ezzati discusses Projections for increases in life expectancy in most of the world’s developed nations by 2030, and the implications for social policy.

Jennifer Downs discusses her Article on the influence of religious leaders in promoting male circumcision as a strategy to decrease HIV transmission in Tanzania.

Melanie Davies and Sudesna Chatterjee discuss a Seminar on type 2 diabetes, and outline plans for a Lancet Diabetes Commission.

Silvia Stringhini discusses a research article which highlights how low socioeconomic status should be considered alongside other established risk factors for non-communicable diseases.

Dr. Meredith Shiels discusses trends in premature mortality in the US since 1999.

John Neoptolomos discusses the ESPAC-4 trial, investigating a chemotherapy drug combination for patients with pancreatic cancer.

Hashim Ahmed discusses his study about the diagnostic accuracy of multi-parametric MRI in detecting clinically significant prostate cancer in men.